Scott Plevy

Company: Protagonist Therapeutics

Job title: Executive Vice President, Head of Discovery and Therapeutic Lead, Gastroenterology

Seminars:

Panel Discussion: Defining Remittive Therapy in Dermatology: Perspectives from Industry Experts 8:30 am

Although an attractive goal, how realistic is being symptom free whilst being treatment free? What does remission actually look like in a dermatology context? Is remittive therapy economically viable? How do you price a drug that cures disease? Does remission include an absence of psychological symptoms?Read more

day: Conference Day Two